Roche looks to personalized medicine for growth

LONDON Wed Sep 5, 2012 12:31pm EDT

The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010. REUTERS/Pascal Lauener

The logo of the Swiss drugmaker Roche is seen on a factory in Burgdorf near Bern November 17, 2010.

Credit: Reuters/Pascal Lauener

Related Topics

LONDON (Reuters) - Roche Holding AG, the world's biggest maker of cancer drugs, said it would build on its drive into personalized medicine to hold onto its long-term growth momentum and said it would keep up spending on research and development.

In a statement ahead of a presentation to investors in London on Wednesday, the Swiss drugmaker said it expected 19 late stage trials to read out over the next 18 months.

"More than 60 percent of our pharmaceutical pipeline projects are coupled with the development of companion diagnostics in order to make treatments more effective," Chief Executive Severin Schwan said in a statement.

Roche said it was committed to a stable R&D budget. It spent 8.3 billion Swiss francs ($8.71 billion)on R&D in 2011. The company is also targeting growth in emerging markets as austerity-hit European markets slash healthcare budgets.

(Reporting by Caroline Copley)

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see
Comments (1)
WitchDrTim wrote:
How is this possible to treat people as individuals and have the drugs approved?

This has been the dispute of Pharmaceutical Companies for years again Homeopathy, that because we treat our patients as individuals, that it is not possible for our medicines to fit into the current clinical trial models and thus it supposedly makes our medicine a farce.

So, someone please explain to me how they will possibly treat people individually and fit into the current models of scientific proof under the current system.

Sep 05, 2012 4:13am EDT  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.